POPH: Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population

Sponsor
Université de Montréal (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02655432
Collaborator
(none)
0
3
5
0
0

Study Details

Study Description

Brief Summary

Screening of haitian children between the ages of 3 and 6 years old for amblyogenic risk factors with the use of the Spot photoscreener. The photoscreener results will be compared to the complete ophthalmologic evaluation. Primarily, this will allow evaluation of the performance of the spot photoscreener in the haitian children population. Secondarily, this study will gather epidemiological information on vision problems in the haitian children population.

Condition or Disease Intervention/Treatment Phase
  • Device: Spot photoscreener
  • Procedure: Ophthalmologic evaluation
  • Procedure: Cyclopleged refraction

Detailed Description

Screening of haitian children between the ages of 3 and 6 years old for amblyogenic risk factors with the use of the Spot photoscreener before and after cycloplegia. The photoscreener results will be compared to the complete ophthalmologic evaluation. The ophthalmologic evaluation includes visual acuity, ocular alignment, slit lamp evaluation, cycloplegic refraction and dilated fundus evaluation. First of all, this will allow evaluation of the performance of the spot photoscreener in the haitian children population. Second of all, this study will gather epidemiological information on vision problems in the haitian children population.

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Évaluation de l'Utilisation d'un Photoscreener Comme méthode de dépistage Des problèmes Ophtalmologiques pédiatriques en Haïti
Study Start Date :
Jan 1, 2016
Actual Primary Completion Date :
Jun 1, 2016
Actual Study Completion Date :
Jun 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Spot photoscreener

Automated vision screener: Spot Vision Screener VS 100, Welch-Allyn. This photoscreener is a portable device, using an infrared light. It is built to detect amblyogenic risk factors. First of all, the spot photoscreener produces a sounds which attracts the child's attention and helps him shift his gaze towards the device, held at 1 meter in front him. The spot then evaluates for refractive errors, anisocoria, strabismus, ptosis and media opacity. The ophthalmologic evaluation consists of the measure of the visual acuity, ocular alignment, anterior and posterior segment. The patient will be cyclopleged with cycloplegic drops and will be refracted to obtain a cyclopleged refraction. This will determine his refractive error.

Device: Spot photoscreener
Screening of vision problem through an automated device

Procedure: Ophthalmologic evaluation
Screening of vision problem through an ophthalmologic evaluation

Procedure: Cyclopleged refraction
Screening of refractive problems through a cyclopleged optometric refraction

Outcome Measures

Primary Outcome Measures

  1. Number of patients presenting significant ophthalmologic pathologies in an haitian pediatric population [7 days]

    The epidemiology of vision problems will be evaluated in a sample of haitian children. The ophthalmologic exam will be considered abnormal if it denotes a significant ophthalmologic pathology. A significant ophthalmologic pathology is defined as a significant refractive error, a significant strabismus or a significant media opacity according to the 2013 American Association for Pediatric Ophthalmology and Strabismus (AAPOS) Guidelines for automated preschool vision screening. An ophthalmologic pathology is also considered significant in cases of severe ophthalmologic pathologies (xerophthalmia, trachoma, cataract >1mm, glaucoma, retinopathy of prematurity, retinoblastoma).

Secondary Outcome Measures

  1. Performance of the Spot photoscreeners in comparison with the ophthalmologic exam to denote significant ophthalmologic pathologies according to the 2013 AAPOS guidelines in an haitian pediatric population [7 days]

    Sensitivity, specificity, positive predictive value and negative predictive value of the abnormal automated vision screening with the photoscreener in comparison of the abnormal screening of the ophthalmologic exam using the criteria of the AAPOS guidelines (gold standard). A significant ophthalmologic pathology is defined as a significant refractive error, a significant strabismus or a significant media opacity according to the 2013 American Association for Pediatric Ophthalmology and Strabismus (AAPOS). The results of the test, being normal vs abnormal, will be compared.

  2. Performance of the Spot photoscreeners in comparison with the ophthalmologic exam to denote severe ophthalmologic pathologies that are not described in the 2013 AAPOS guidelines in an haitian pediatric population [7 days]

    Sensitivity, specificity, positive predictive value and negative predictive value of the abnormal automated vision screening with the photoscreener in comparison of the abnormal screening of the ophthalmologic exam for all other severe ophthalmologic pathologies not described in the AAPOS guidelines (gold standard). An ophthalmologic pathology is also considered significant in cases of severe ophthalmologic pathologies (xerophthalmia, trachoma, cataract >1mm, glaucoma, retinopathy of prematurity, retinoblastoma). The results of the test, being normal vs abnormal, will be compared.

  3. Performance of the Spot photoscreeners in comparison with the cyclopleged optometric exam in an haitian pediatric population [7 days]

    Sensitivity, specificity of the refractive errors measured with the photoscreener compared to the refractive errors measured by the cyclopleged optometric exam (gold standard). The values of the refraction, in dioptries, will be compared.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 6 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Haitian children aged 3-6 years of age

  • Signed consent form from a legal guardian

Exclusion Criteria:
  • Previous vision problem diagnostic

  • Unsigned consent form

Contacts and Locations

Locations

Site City State Country Postal Code
1 École Adventiste de Limbé Limbé Haiti
2 École Saint-Dominique de Plaine du nord Plaine du Nord Haiti
3 ClinicA Pétionville Haiti

Sponsors and Collaborators

  • Université de Montréal

Investigators

  • Principal Investigator: Antoine Sylvestre-Bouchard, Université de Montréal
  • Study Chair: Patrick Hamel, MD, FRCS, Université de Montréal
  • Study Director: Christelle Doyon, MD, Université de Montréal

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Patrick Hamel, Hospital chef of the ophthalmology department, CHU Sainte-Justine, Université de Montréal
ClinicalTrials.gov Identifier:
NCT02655432
Other Study ID Numbers:
  • 20160130
First Posted:
Jan 14, 2016
Last Update Posted:
Dec 2, 2016
Last Verified:
Nov 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 2, 2016